Skip to content

Clinical trials

Asthma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Country / region: United States Clear all

1,586 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200113
200225
200341
200445
200553
200682
200785
200890
200971
201090
201172
201287
201376
201464
201578
201664
201778
201859
201960
202044
202157
202240
202347
202443
202531
202646

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,181
Terminated140
Recruiting99
Withdrawn54
Unknown status47
Active, not recruiting46
Not yet recruiting9
Enrolling by invitation8
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline108
AstraZeneca84
Teva Branded Pharmaceutical Products R&D, Inc.41
Novartis Pharmaceuticals36
Brigham and Women's Hospital35
National Institute of Allergy and Infectious Diseases (NIAID)34
University of California, San Francisco33
Johns Hopkins University28
Sanofi27
National Institute of Environmental Health Sciences (NIEHS)25

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma1,586
Pulmonary Disease, Chronic Obstructive104
Hypersensitivity72
Lung Diseases61
Obesity51
Respiratory Sounds37
Respiratory Tract Diseases31
Diabetes Mellitus30
Heart Failure30
Rhinitis, Allergic28

Trials

Showing 1 to 25 of 1,586. Each trial links to its page on Pharma Observatory.

1,486 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.